Home > Financial Ratios > LACTOSE (INDIA)

LACTOSE (INDIA)
Core EBITDA Growth

    Back to All Ratios
LACTOSE (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LACTOSE (INDIA)
Please provide your vote to see the results

LACTOSE (INDIA) Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -8.5666.44-5.7996.48-31.65

What is the latest Core EBITDA Growth ratio of LACTOSE (INDIA) ?

The latest Core EBITDA Growth ratio of LACTOSE (INDIA) is -8.56 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-8.56
Mar202466.44
Mar2023-5.79
Mar202296.48
Mar2021-31.65

How is Core EBITDA Growth of LACTOSE (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2025 -8.56
Negative
Mar2024 66.44
Positive
Mar2023 -5.79
Negative
Mar2022 96.48
Positive
Mar2021 -31.65 -

Other Financial Ratios of LACTOSE (INDIA)


Compare Core EBITDA Growth ratio of peers of LACTOSE (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LACTOSE (INDIA) ₹132.4 Cr -3.4% -3% 0.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,408.0 Cr 1.8% 5.6% 16.7% Stock Analytics
DIVIS LABORATORIES ₹206,906.0 Cr 0.5% 13.1% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,521.0 Cr -2.7% 5.1% 42.4% Stock Analytics
CIPLA ₹119,032.0 Cr 2.1% -0.6% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.1 Cr -4% -17.5% -8.6% Stock Analytics


LACTOSE (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

-3.4%

-3%

0.3%

SENSEX

1.2%

1.2%

-5.5%


You may also like the below Video Courses